ANG LI to Tumor Lysis Syndrome
This is a "connection" page, showing publications ANG LI has written about Tumor Lysis Syndrome.
Connection Strength
0.781
-
Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification. J Oncol Pharm Pract. 2020 Apr; 26(3):529-535.
Score: 0.620
-
Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia. Leuk Res. 2020 02; 89:106298.
Score: 0.161